cannabis indica

Índice completo — página 49 de 77

Estudos 4.801 a 4.900 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2018 a 2017. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 4.801 a 4.900

  1. 2018

    Will Widespread Synthetic Opioid Consumption Induce Epigenetic Consequences in Future Generations?

    InconclusivoMetanáliseDependência — Opioides
  2. 2018

    α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model

    FavorávelEstudo em AnimaisCâncerCâncer — Próstata
  3. 2018

    α-Terpineol, a natural monoterpene: A review of its biological properties

    FavorávelMetanáliseDorCâncerInflamação+6
  4. 2018

    β-Caryophyllene (BCP) ameliorates MPP+ induced cytotoxicity.

  5. 2018

    Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure

    FavorávelEstudo em AnimaisGlaucomaTetraidrocanabinol (THC)
  6. 2018

    Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats.

  7. 2018

    Δ9-Tetrahydrocannabinold (THC) suppresses secretion of IFNα by plasmacytoid dendritic cells (pDC) from healthy and HIV-infected individuals.

    FavorávelEstudo LaboratorialHIV/AIDS
  8. 2017

    (+)-Borneol Improves the Efficacy of Edaravone Against DSS-induced Colitis by Promoting M2 Macrophages Polarization via JAK2-STAT3 Signaling Pathway

    FavorávelEstudo LaboratorialDII — Doença Inflamatória Intestinal
  9. 2017

    (+)-Borneol is neuroprotective against permanent cerebral ischemia in rats by suppressing production of proinflammatory cytokines

    FavorávelEstudo em AnimaisAVC
  10. 2017

    [Effect factors and mechanisms of borneol's bidirectional regulation on blood-brain barrier permeability]

    InconclusivoMetanálise
  11. 2017

    2-Arachidonoylglycerol as a possible treatment for anorexia nervosa in animal model in mice

  12. 2017

    A Cannabigerol-rich Cannabis Sativa Extract, Devoid Of Delta 9-tetrahydrocannabinol, Elicits Hyperphagia In Rats

  13. 2017

    A Chronic Low Dose Of Δ9-tetrahydrocannabinol (THC) Restores Cognitive Function In Old Mice

  14. 2017

    A clinical and mechanistic study of topical borneol‐induced analgesia.

    FavorávelEnsaio Clínico Duplo-CegoDorDor — Aguda
  15. 2017

    A placebo controlled study of quetiapine-XR in bipolar depression accompanied by generalized anxiety with and without a recent history of alcohol and cannabis use

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis+4
  16. 2017

    A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by Modulating the Endocannabinoid System in HT22 Cells

  17. 2017

    A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults

    InconclusivoEnsaio Clínico Duplo-CegoDependência QuímicaEfeitos Adversos da CannabisDependência — Cannabis
  18. 2017

    A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery

  19. 2017

    A selective review of medical cannabis in cancer pain management.

  20. 2017

    A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study.

    FavorávelEnsaio Clínico Duplo-CegoDoenças Cardiovasculares (DCV)Hipertensão Arterial
  21. 2017

    A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial

    FavorávelEnsaio Clínico Duplo-CegoInflamaçãoDermatite de Contato AlérgicaEczema
  22. 2017

    A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia

    FavorávelMetanáliseInflamaçãoDisfunção CognitivaPsicose+6
  23. 2017

    Activation of cannabinoid receptor type 2 by JWH133 alleviates bleomycin-induced pulmonary fibrosis in mice

  24. 2017

    Acute effects of synthetic cannabinoids: Update 2015

  25. 2017

    Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial

  26. 2017

    Acute Poisonings from Synthetic Cannabinoids — 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010–2015

  27. 2017

    Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two

    InconclusivoEstudo LaboratorialÁcido Tetraidrocanabinólico (THC-a)
  28. 2017

    Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE).

  29. 2017

    Ameliorative effect of borneol, a natural bicyclic monoterpene against hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic Wistar rats

    FavorávelEstudo em AnimaisInflamaçãoDoenças Cardiovasculares (DCV)Diabetes
  30. 2017

    Anti-excitotoxic effects of cannabidiol are partly mediated by enhancement of NCX2 and NCX3 expression in animal model of cerebral ischemia.

    FavorávelEstudo em AnimaisAVC
  31. 2017

    Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.

  32. 2017

    Anti-inflammatory ω-3 endocannabinoid epoxides

    FavorávelMetanáliseInflamaçãoAnandamida (AEA)Ômega-3
  33. 2017

    Anticancer Effects Of Phytocannabinoids Used With Chemotherapy In Leukaemia Cells Can Be Improved By Altering The Sequence Of Their Administration

    FavorávelEstudo LaboratorialCâncerCâncer — LeucemiaTetraidrocanabinol (THC)Canabigerol (CBG)
  34. 2017

    Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB‐13, in mice

  35. 2017

    Antifungal graphene oxide-borneol composite

    FavorávelEstudo LaboratorialInfecções Fúngicas
  36. 2017

    Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative.

  37. 2017

    Aromatherapy Improves Work Performance Through Balancing the Autonomic Nervous System

    FavorávelEnsaio Clínico Duplo-Cego
  38. 2017

    Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy.

    FavorávelEstudo em AnimaisEpilepsia
  39. 2017

    Association Between Marijuana Use and Sexual Frequency in the United States: A Population-Based Study

    FavorávelMetanáliseLibidoDisfunção Erétil
  40. 2017

    Association between serum phospholipid fatty acid levels and adiposity in Mexican women

  41. 2017

    Associations between Cannabis Use and Physical Health Problems in Early Midlife: A Longitudinal Comparison of Persistent Cannabis versus Tobacco Users

    DesfavorávelMetanáliseInflamaçãoSíndrome MetabólicaDoença Periodontal
  42. 2017

    Associations between medical cannabis and prescription opioid use in chronic pain patients: A preliminary cohort study.

    FavorávelEnsaio ClínicoDorDependência QuímicaDor — Crônica+1
  43. 2017

    Beta-caryophyllene Protects Against Alcoholic Steatohepatitis By Attenuating Inflammation And Metabolic Dysregulation In Mice

    FavorávelEstudo em AnimaisEstresse OxidativoEsteatose HepáticaDoença Hepática Alcoólica
  44. 2017

    Big conductance calcium-activated potassium channel openers control spasticity without sedation

  45. 2017

    Bladder Cancer Cell Growth and Motility Implicate Cannabinoid 2 Receptor-Mediated Modifications of Sphingolipids Metabolism

    FavorávelEstudo LaboratorialCâncerCâncer — BexigaCanabinoides Sintéticos JWH-x
  46. 2017

    Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.

    FavorávelEstudo em AnimaisInflamaçãoObesidadeDiabetesCanabinoides Sintéticos SR-xMicrobioma+2
  47. 2017

    Blunted stress reactivity in chronic cannabis users.

    FavorávelEnsaio Clínico
  48. 2017

    Borneol Attenuates Ultrasound-Targeted Microbubble Destruction-Induced Blood–Brain Barrier Opening in Focal Cerebral Ischemia

    FavorávelEstudo em AnimaisAVC
  49. 2017

    Borneol enhances the antidepressant effects of asiaticoside by promoting its distribution into the brain

    FavorávelEstudo em AnimaisDepressão
  50. 2017

    Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication

    InconclusivoEnsaio ClínicoDependência QuímicaDependência — Cannabis
  51. 2017

    Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury

    FavorávelEstudo em AnimaisLesões da Medula Espinhal
  52. 2017

    Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon.

  53. 2017

    Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.

    FavorávelEnsaio ClínicoEpilepsiaEpilepsia — FIRESCBD Farmacêutico
  54. 2017

    Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoSíndrome Metabólica+2
  55. 2017

    Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neuron.

    FavorávelEstudo LaboratorialDoenças Cardiovasculares (DCV)Doenças NeurodegenerativasAVC+1
  56. 2017

    Cannabidiol Attenuates Seizures And Social Deficits In A Mouse Model Of Dravet Syndrome

    FavorávelEstudo em AnimaisEpilepsiaEpilepsia — Síndrome de DravetAutismo
  57. 2017

    Cannabidiol Does Not Dampen Responses To Emotional Stimuli In Healthy Adults

    InconclusivoEnsaio Clínico Duplo-CegoAnsiedade
  58. 2017

    Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats.

    FavorávelEstudo em AnimaisDorDor — Aguda
  59. 2017

    Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke.

    FavorávelEstudo em AnimaisDoenças NeurodegenerativasAVC
  60. 2017

    Cannabidiol reduces ethanol consumption, motivation and relapse in mice.

    FavorávelEstudo em AnimaisDependência QuímicaDependência — Álcool
  61. 2017

    Cannabidiol Reduces Leukemic Cell Size – But Is It Important?

    FavorávelEstudo LaboratorialCâncerCâncer — Leucemia
  62. 2017

    Cannabidiol Regulation Of Emotion And Emotional Memory Processing: Relevance For Treating Anxiety-related And Substance Abuse Disorders

    FavorávelMetanáliseAnsiedadeTEPT
  63. 2017

    Cannabidiol restores intestinal barrier dysfunction and inhibits the apoptotic process induced by Clostridium difficile toxin A in Caco-2 cells

    FavorávelEstudo LaboratorialDiarreiaCanabinoides Sintéticos AM-x
  64. 2017

    Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome

    FavorávelEnsaio ClínicoSíndrome de Sturge-Weber
  65. 2017

    Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK.

    FavorávelEstudo LaboratorialCâncerCâncer — MelanomaCâncer — Pele (não melanoma)+1
  66. 2017

    Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity.

    FavorávelEstudo em AnimaisDorDor — AgudaTetraidrocanabinol (THC)
  67. 2017

    Cannabidiol, A Novel Inverse Agonist For GPR12

    FavorávelEstudo LaboratorialCâncerCâncer — Metastático
  68. 2017

    Cannabidiol: Swinging The Marijuana Pendulum From 'Weed' To Medication To Treat The Opioid Epidemic

    FavorávelMetanáliseDependência QuímicaDependência — Opioides
  69. 2017

    Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

  70. 2017

    Cannabidiolic Acid-mediated Selective Down-regulation Of C-fos In Highly Aggressive Breast Cancer MDA-MB-231 Cells: Possible Involvement Of Its Down-regulation In The Abrogation Of Aggressiveness

    FavorávelEstudo LaboratorialCâncerCâncer — MamaÁcido Canabidiólico (CBD-a)
  71. 2017

    Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy

  72. 2017

    Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity‐based anorexia

  73. 2017

    Cannabinoid CB2 Receptors are Involved in the Protection of RAW264.7 Macrophages Against the Oxidative Stress: An in Vitro Study

  74. 2017

    Cannabinoid Derivatives Exert a Potent Anti-Myeloma Activity Both in Vitro and in Vivo

    FavorávelEstudo em AnimaisCâncer — MielomaCanabinoides Sintéticos WIN-x
  75. 2017

    Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment

    DesfavorávelMetanáliseNáusea e VômitoSíndrome da Hiperêmese Canabinoide
  76. 2017

    Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  77. 2017

    Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review

    InconclusivoMetanáliseSíndrome da Hiperêmese Canabinoide
  78. 2017

    Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network

    DesfavorávelMetanáliseSíndrome da Hiperêmese Canabinoide
  79. 2017

    Cannabinoid Receptor 2 Signaling In Neurodegenerative Disorders: From Pathogenesis To A Promising Therapeutic Target

  80. 2017

    Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn’s Disease

  81. 2017

    Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia

  82. 2017

    Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.

    FavorávelEstudo em AnimaisAVCCanabinoides Sintéticos SR-xCanabinoides Sintéticos JWH-x
  83. 2017

    Cannabinoids and Pain: Sites and Mechanisms of Action.

  84. 2017

    Cannabinoids and the kidney: effects in health and disease

  85. 2017

    Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?

  86. 2017

    Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis.

    FavorávelMetanáliseEsclerose Múltipla
  87. 2017

    Cannabinoids In Attention-deficit/hyperactivity Disorder: A Randomised-controlled Trial

    FavorávelEnsaio Clínico Duplo-CegoTDA e TDAHTetraidrocanabinol (THC)THC:CBD Farmacêutico
  88. 2017

    Cannabinoids in Pain Management and Palliative Medicine

    InconclusivoMetanáliseCuidados Paliativos
  89. 2017

    Cannabinoids in Parkinson's Disease

    InconclusivoMetanáliseDoença de Parkinson
  90. 2017

    Cannabinoids in treatment-resistant epilepsy: A review.

  91. 2017

    Cannabinoids Regulate the Diameter of Pericyte-Containing Retinal Capillaries in Rats

    FavorávelEstudo em AnimaisDorDor — OcularAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+3
  92. 2017

    Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation.

    FavorávelEstudo LaboratorialPsoríaseCanabinoides Sintéticos JWH-x
  93. 2017

    Cannabis and cognitive functioning in multiple sclerosis: The role of gender

  94. 2017

    Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients

    FavorávelEnsaio ClínicoDorDor — CrônicaDor — Oncológica
  95. 2017

    Cannabis and lung. What we know and everything we don't know yet.

    InconclusivoMetanáliseDPOC
  96. 2017

    Cannabis and Pain: A Clinical Review

    FavorávelMetanáliseDorDor — CrônicaDependência — Opioides
  97. 2017

    Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report

    FavorávelMetanáliseDorDependência QuímicaDor — Crônica+1
  98. 2017

    Cannabis as a substitute for prescription drugs - a cross-sectional study.

    FavorávelMetanáliseDorAnsiedadeDor — Crônica+2
  99. 2017

    Cannabis constituent synergy in a mouse neuropathic pain model

  100. 2017

    Cannabis for restless legs syndrome: a report of six patients

    FavorávelMetanáliseSíndrome das Pernas Inquietas